Trial Profile
Use of incobotulinumtoxinA (Xeomin) in patients with a recurrent diplopia after onabotulinumtoxinA (DYSPORT) injections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Blepharospasm; Hemifacial spasm
- Focus Adverse reactions
- 21 Dec 2015 New trial record